Top Markets
#1 QuantixAI QuantixAI +105.36%
#2 龙虾 (Lobster) 龙虾 (Lobster) +70.95%
#3 Pons Pons +31.22%
#4 MetaDAO MetaDAO +28.82%
#5 Rain Rain +22.55%
#6 Bedrock Bedrock +21.25%
#7 Ontology Gas Ontology Gas +17.40%
#8 Prom Prom +14.68%
#9 Humanity Humanity +14.44%
#10 Stacks Stacks +13.98%
Coin of the day
QuantixAI QuantixAI
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Hyloris Pharmaceuticals S.A. Hyloris Pharmaceuticals S.A.

Hyloris Pharmaceuticals S.A.

HYL
Clasificación en acciones #19935
Hyloris Pharmaceuticals SA is dedicated to developing, manufacturing, and... Hyloris Pharmaceuticals SA is dedicated to developing, manufacturing, and bringing to market pharmaceutical products designed to fulfill critical unmet medical needs. The company's focus areas include cardiovascular health, oncology, women's health, and other significant therapeutic domains. Its cardiovascular portfolio features treatments for conditions such as atrial fibrillation, acute coronary syndrome, advanced and congestive heart failure, and coronary heart disease. Beyond this, Hyloris addresses a diverse range of other ailments, including post-operative pain management, dental indications, severe and recurring vulvovaginal candidiasis, specific cancers (like acute myeloid leukemia and small cell lung cancer), interstitial cystitis/painful bladder syndrome (IC/PBS), attention deficit hyperactivity disorder (ADHD), and various viral infections. Established in 2012, Hyloris Pharmaceuticals SA is headquartered in Liège, Belgium.
Precio por acción
$5.22
Capitalización bursátil
$146.14M
Cambio (1 día)
-1.35%
Cambio (1 año)
-32.16%
País
BE
Comercio Hyloris Pharmaceuticals S.A. (HYL)

Categoría

Healthcare
Ratio P/B de Hyloris Pharmaceuticals S.A. (HYL)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Hyloris Pharmaceuticals S.A., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Hyloris Pharmaceuticals S.A. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH